Massive Bio is proud to be selected as a part of Fast Company’s Startup 100 list. During Fast Company’s Corporate & Startup Day on November 11th, 2021, a jury including 13 of the leading entrepreneurs in Turkey were asked to name their top 10 startups in Turkey. To be mentioned alongside the other startups with remarkable accomplishments is a great honor and Massive Bio will continue to champion the clinical trial journey of cancer patients all around the globe.
Fast Company is a business media brand in Turkey, with an editorial focus on innovation in technology, leadership, world changing ideas, creativity, and design. Corporate & Startup Day is held by Fast Company Turkey Magazine with Endeavor Turkey, Özyeğin University, Entrepreneurial Institutions Platform and with contributions from MEXT and Esas Holding. Launched in November 1995 by Alan Webber and Bill Taylor, two former Harvard Business Review editors, Fast Company magazine was founded on a single premise: A global revolution was changing business, and business was changing the world.
Other than the Startup 100 list, several other awards were given during the Corporate & Startup Day such as the top 3 institutions friendliest to startups, Best Intrapreneurship Project, and Most Influential Institution & Entrepreneurship Collaboration Awards.
Massive Bio was selected to this list because of the attention gained in the healthcare industry for the SYNERGY-Artificial Intelligence (AI) clinical trial matching program, which has led to gaining recognition of Fast Company and others. “We are very excited to be included in this list with many other prominent startups from Turkey and are extremely optimistic about what the future holds for Massive Bio,” stated Selin Kurnaz, Co-Founder and CEO of Massive Bio. Read more about the 100 Startup list and Fast Company’s Corporate & Startup Day on their website here.
